Strategy for repeat prostate biopsy: Predictors of positive biopsy and additional biopsy location

被引:2
作者
Katto, Kazunobu [1 ]
Takahashi, Masayuki [1 ]
Taue, Ryuichi [1 ]
Nakatsuji, Hiroyoshi [1 ]
Kishimoto, Tomoteru [1 ]
Izaki, Hirofumi [1 ]
Oka, Natsuo [1 ]
Fukumori, Tomoharu [1 ]
Nishitani, Masa-Aki [1 ]
Kanayama, Hiro-Omi [1 ]
机构
[1] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Urol, Tokushima 7708503, Japan
关键词
prostate cancer; radical prostatectomy; repeat biopsy; biopsy location;
D O I
10.1159/000144056
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We analyzed patterns of tumor distribution in radical prostatectomy specimens from patients with repeat biopsies to determine additional appropriate biopsy locations for repeat biopsy. Methods: Between January 2000 and June 2005, a total of 382 patients underwent transrectal ultrasound-guided prostate biopsy. Of these, 47 patients underwent repeat biopsy. Radical prostatectomy was performed for 7 of 22 cancer-positive cases. The 7 specimens were superimposed to create an idealized prostate gland at 3 levels: apex, mid-prostate, and base. We compared these tumor maps with those from 35 initial biopsy positive patients. Results: Prostate cancer was detected in 22 of 47 patients who underwent repeat biopsy. Tumor mapping showed that tumors detected on repeat biopsy in comparison with tumor maps of initial biopsy were dense at the periurethral area of the apex in prostate. Conclusions: Additional biopsy cores taken from periurethral area of the apex on repeat biopsy might further enhance the detection of cancers. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 21 条
  • [1] A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
    Babaian, RJ
    Toi, A
    Kamoi, K
    Troncoso, P
    Sweet, J
    Evans, R
    Johnston, D
    Chen, M
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01) : 152 - 157
  • [2] Prostate-specific antigen: Current status
    Brawer, MK
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 1999, 49 (05) : 264 - 281
  • [3] Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial
    Catalona, WJ
    Partin, AW
    Slawin, KM
    Brawer, MK
    Flanigan, RC
    Patel, A
    Richie, JP
    deKernion, JB
    Walsh, PC
    Scardino, PT
    Lange, PH
    Subong, ENP
    Parson, RE
    Gasior, GH
    Loveland, KG
    Southwick, PC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19): : 1542 - 1547
  • [4] CHAN DW, 1999, DRE J UROL, V161, P95
  • [5] Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO
  • [6] 2-D
  • [7] Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: When should we stop?
    Djavan, B
    Ravery, V
    Zlotta, A
    Dobronski, P
    Dobrovits, M
    Fakhari, M
    Seitz, C
    Susani, M
    Borkowski, A
    Boccon-Gibod, L
    Schulman, CC
    Marberger, M
    [J]. JOURNAL OF UROLOGY, 2001, 166 (05) : 1679 - 1683
  • [8] Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer
    Epstein, JI
    Walsh, PC
    Sauvageot, J
    Carter, HB
    [J]. JOURNAL OF UROLOGY, 1997, 158 (05) : 1886 - 1890
  • [9] Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
    Eskew, LA
    Bare, RL
    McCullough, DL
    [J]. JOURNAL OF UROLOGY, 1997, 157 (01) : 199 - 202
  • [10] Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate
    Fleshner, NE
    OSullivan, M
    Fair, WR
    [J]. JOURNAL OF UROLOGY, 1997, 158 (02) : 505 - 508